AH Lisanti Capital Growth »

Viking Therapeutics shares owned by AH Lisanti Capital Growth

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by AH Lisanti Capital Growth from 13F filings

Historical chart of AH Lisanti Capital Growth investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by AH Lisanti Capital Growth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by AH Lisanti Capital Growth

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 349k 18.61
2023-03-31 $5.8M 350k 16.65

More positions owned by AH Lisanti Capital Growth

Modine Manufacturing (MOD)
Nutanix Cl A (NTNX)
Transmedics Group (TMDX)
Topbuild (BLD)
Pinnacle Financial Partners (PNFP)
Abercrombie & Fitch Cl A (ANF)
Applied Industrial Technologies (AIT)
Webster Financial Corporation (WBS)
Elf Beauty (ELF)
Q2 Holdings (QTWO)
Varonis Sys (VRNS)
Freshworks Class A Com (FRSH)
FormFactor (FORM)
Axonics Modulation Technolog (AXNX)
Viking Therapeutics (VKTX)

View all positions for AH Lisanti Capital Growth

Top funds holding Viking Therapeutics

Vanguard Group
Viking Global Investors
Alliancebernstein
Balyasny Asset Management
Deerfield Management Company
Goldman Sachs Group
Perpetual
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of America Corporation
Eventide Asset Management
Massachusetts Financial Services
683 Capital Management
5AM Venture Management
Citadel Advisors

View all funds holding Viking Therapeutics